JD Supra Law

DECEMBER 12, 2023

This week we welcome back our previous guest, Laura Gunter, President of the NC Life Sciences Organization, formally known as NCbio. Listen to episode 171 now. By: Maynard Nexsen

Marketing 65

Marketing Marketing 65

JD Supra Law

MAY 23, 2023

As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the tech industry. Though not to an equal degree, the biotechnology, pharmaceutical, and life science industries have not been excluded from employment cuts.

Patent Application 98

Patent Application Patent 98

JD Supra Law

MARCH 13, 2024

Join BioUtah president & CEO Kelvyn Cullimore and Mayer Brown’s Vera Nackovic in a discussion about current trends and issues in the life sciences industry. By: Mayer Brown

65

65

JD Supra Law

SEPTEMBER 26, 2023

We are excited to announce Venable’s inaugural Life Sciences Webinar Series. This month-long series will explore the intricacies and latest developments that shape the life sciences industry.

Intellectual Property 82

Intellectual Property Privacy Law 82

JD Supra Law

MARCH 29, 2024

The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. By: MoFo Life Sciences Many believe this is only the beginning.

Marketing 65

Marketing Marketing Technology 65

JD Supra Law

SEPTEMBER 27, 2023

We are excited to announce Venable’s inaugural Life Sciences Webinar Series. This month-long series will explore the intricacies and latest developments that shape the life sciences industry.

73

73

JD Supra Law

SEPTEMBER 22, 2023

We are excited to announce Venable’s inaugural Life Sciences Webinar Series. This month-long series will explore the intricacies and latest developments that shape the life sciences industry.

Business 73

Business IP 73

JD Supra Law

OCTOBER 3, 2023

We are excited to announce Venable’s inaugural Life Sciences Webinar Series. This month-long series will explore the intricacies and latest developments that shape the life sciences industry.

Litigation 70

Litigation 70

JD Supra Law

DECEMBER 20, 2022

As the industry readies itself for the January 2023 pilgrimage to the J.P. Morgan Healthcare Conference (JPM) and Biotech Showcase in San Francisco, our market-leading life sciences and health care industry team has prepared a series of updates that we hope will help strategically guide your 2023 partnering and investment decisions.

Marketing 96

Marketing Marketing 96

JD Supra Law

OCTOBER 17, 2023

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Tokyo, where Hogan Lovells Tokyo office managing partner and Asia-Pacific (APAC) lead for the Life Sciences and Health Care sector Dr Frederick Ch’en, and partners Melissa Bianchi, Penny Powell, Cullen Taylor, and Hein van den Bos discussed the commercialization (..)

73

73

IP Law 360

FEBRUARY 27, 2024

Sheppard Mullin Richter & Hampton LLP expanded its intellectual property services on the West Coast this week with the addition of a patent prosecutor specializing in the life sciences industry.

Intellectual Property 52

Intellectual Property IP Patent 52

JD Supra Law

OCTOBER 25, 2022

Life science companies are increasingly turning to international arbitration as a preferred dispute-resolution mechanism due to its confidentiality, comparative cost-effectiveness, and nearly universal enforceability.

Confidentiality 97

Confidentiality Reporting 97

JD Supra Law

MAY 10, 2023

Many stakeholders in the AgTech industry are interested in collaborating with or obtaining funding from the United States Department of Agriculture (USDA), but are unsure what implications such collaborations may have on their intellectual property (IP) obligations, opportunities, and strategy. By: MoFo Life Sciences

IP 98

IP Intellectual Property 98

IP Watchdog

DECEMBER 14, 2023

These cases will have an especially significant impact on the life sciences industry, and watching how these decisions are applied by the district courts should be a priority for practitioners in this space. Eli Lilly decisions provide a glimpse into what litigants can expect in the aftermath of the GSK v. Teva and Amgen v.

Litigation 97

Litigation IP Patent Infringement Intellectual Property 97

McKinsey Operations

DECEMBER 14, 2022

As the life sciences industry is tested by an uncertain economic environment, companies can focus not only on resilience but on positioning themselves to accelerate when coming out of the downturn.

90

90

JD Supra Law

MAY 3, 2023

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Boston for the first time since the pandemic.

Litigation 98

Litigation 98

Velocity of Content

APRIL 3, 2024

A highlight of the Copyright in Medical Communications Community is Industry Insights, where experienced, in-the-field professionals will share their perspectives on common copyright compliance challenges in medical communications in response to a new question featured every week.

Copyright 80

Copyright Journalism Publishing Designs 80

JD Supra Law

SEPTEMBER 13, 2023

Attend ACI’s Hatch-Waxman and BPCIA Proficiency Series from October 10-26, a virtual three-week program designed to provide new lawyers and executives for the life sciences industry with a solid foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA litigation and regulation.

Litigation 75

Litigation Designs Design Business 75

SpicyIP

FEBRUARY 7, 2022

Although the business and innovation practices of the pharmaceutical industry are largely based on patents, other intellectual property rights including trade marks and trade secrets are highly relevant too. Overview of the pharmaceutical industry and national systems of innovation. What does the pharmaceutical industry patent?

Intellectual Property 98

Intellectual Property Law Government IP 98

JD Supra Law

FEBRUARY 13, 2023

The past year brought many developments in the life sciences patent legal space. Three decisions in particular hold potential ramifications for drug makers and patent holders in 2023. By: McDermott Will & Emery

Patent 89

Patent IP 89

The IPKat

JULY 31, 2023

Kat summit The IPKat is pleased to inform readers that this year’s Life Sciences Strategy Summit on IP & Exclusivity will be held on 9, 10, 11 October 2023 in Munich (Germany).

IP 52

IP Editing Intellectual Property Patent 52

JD Supra Law

MARCH 16, 2022

That question continues to dog applicants in the biopharmaceutical industry, particularly in view of recent Federal Circuit decisions concerning whether a patent application provides adequate written description for claims requiring functional limitations, such as administering an “effective” amount of a therapy. By: MoFo Life Sciences

Patent Application 98

Patent Application Patent 98

Velocity of Content

JANUARY 9, 2024

Ignoring Copyright is Risky Business Research in the life sciences depends in part on the ability to acquire and share scientific information, particularly journal articles, in a timely manner. On average, 33% of respondents in Life Sciences reported a fully remote work environment and 28% reported a hybrid environment.

Copyright 94

Copyright Journalism Licensing Copyright Infringement 94

IP Watchdog

OCTOBER 16, 2023

The House Subcommittee on Courts, Intellectual Property, and the Internet holds a hearing on IP competition with China and another subcommittee discusses safeguarding data in the growing AI industry. Elsewhere, IPWatchdog is hosting its Life Sciences Masters™ program in Ashburn, VA, and the U.S.

IP 59

IP Intellectual Property Branding Brands 59

JD Supra Law

JANUARY 25, 2022

This is the only industry-shaping event that has consistently brought together the “Who’s Who” of the European Life Sciences Patent Bar for the past 15 years. By: American Conference Institute (ACI)

Litigation 98

Litigation Patent 98

The IPKat

AUGUST 22, 2023

Freedom to Operate for Life Sciences and Pharma – 25th and 26th October 2023 The 2-day course delivered in the form of webinar will allow the attendees to learn how to identify and deal with third party chemical, biological and device patents in the Life Science and Pharmaceutical Industries. More details here.

Intellectual Property 52

Intellectual Property Confidentiality IP Licensing 52

JD Supra Law

MARCH 10, 2022

In an open letter posted on February 26, six life sciences business leaders called on other members of their industry "to cease all business involvement in Russia."

Business 98

Business 98

Fish & Richardson Trademark & Copyright Thoughts

SEPTEMBER 30, 2022

Fish & Richardson has received four coveted “Highly Recommended” rankings from LMG Life Sciences in the areas of General Patent Litigation , Hatch-Waxman Patent Litigation (Branded) , Patent Prosecution , and Patent Strategy and Management. Gwilym Attwell. Tony Zhang.

Intellectual Property 52

Intellectual Property Patent Prosecution Litigation Branding 52

JD Supra Law

AUGUST 16, 2023

Hosted by C5 Group, the 21st Annual Life Sciences IP Summit returns for another exciting year with curated programming with speakers from the pharma, biotech and medical device industries that will provide practical insights on procuring and maintaining patents in the Unitary Patent era, as well as provide you with offensive and defensive patent litigation (..)

IP 52

IP Litigation Patent 52

IAM Magazine

SEPTEMBER 29, 2022

In the life sciences industry, patent protection for innovative medicinal products is pivotal to the commercial success of new drug products.

Law 52

Law Patent 52

IP Watchdog

OCTOBER 25, 2022

During IPWatchdog’s Life Sciences Masters 2022 today, Retired Chief Judge of the U.S. patent eligibility law on the life sciences industry, including the potential impact of current efforts to reform patent eligibility law, such as Senator Thom Tillis’ (R-NC) Patent Eligibility Restoration Act.

Law 69

Law Patent Government Litigation 69

The IPKat

SEPTEMBER 21, 2022

9th Pan-European LES YMC Conference - 30 September 2022 – Milan – in person The 9th Pan-European LES YMC Conference " SPORT AND BEYOND: IP and Competition in the Sport Industry " will take place in Milan on 30 September 2022. For more information, a list of panelists and to register for the event, click here.

Intellectual Property Law 76

Intellectual Property Law Intellectual Property Registration IP 76

JD Supra Law

MAY 24, 2023

While the parties obtained finality, many in the pharmaceutical and biotechnology industries received the opinion under a cloud of uncertainty and concern for exclusivity rights broad enough to both protect clinical candidates and deter competitors. By: Proskauer - Life Sciences

Patent 52

Patent 52

The IPKat

MARCH 2, 2022

He is the author of over 60 publications on intellectual property law and is co-editor of the Research Handbook on Intellectual Property and the Life Sciences. She has gained extensive experience advising a wide range of companies within the life sciences industry, including pharma, MedTech, healthcare and food companies.

Intellectual Property 95

Intellectual Property Intellectual Property Law IP Patent Law 95

Velocity of Content

SEPTEMBER 22, 2022

More and more, the term deep search is being buzzed about in industries that rely on having the most up to date information– areas like life sciences, biotechnology, chemicals, and agriculture. . Q: Can you give an example of what deep search capabilities look like in the context of a life sciences company? .

Invention 93

Invention Licensing Business Technology 93

Trading Secrets

JULY 21, 2023

Initially, Catapult did not make placements in the life sciences industry, instead focusing on the tech, light industrial, accounting, and finance industries.

Confidentiality 52

Confidentiality Privacy Litigation 52

JD Supra Law

NOVEMBER 4, 2022

The COVID-19 pandemic has accelerated the globalization of the life sciences industry, driving cross-border collaborations to develop urgently needed treatments, scale up manufacturing and distribution, and fill raw material shortages worldwide.

55

55